Week 6 - An Intractable Problem Flashcards
What is pharmacodynamics?
The effect of the drug on the body
e.g. What are the changes in the body after taking this drug? (lower BP)
What is the definition of absorption as part of ADME?
Process by which drug moves from its site of administration to the systemic circulation
Via:
- Passive diffusion
Lipophilic drugs: cross membrane ‘transcellular’
Hydrophilic drugs: Low molecular weight hydrophilic drugs, pores and gap junctions
- Active transport (large molecular weight drugs, ATP-dependent transporter)
What is pharmacokinetics?
The effect of the body on the drug
e.g. How does body respond to the drug? ADME
List FOUR pieces of information which are found on a medical license
2 marks
The licence for a medicine includes information such as: (Any for ½ mark each)
· What health condition it should be used to treat
· What dose should be used
· What form it takes – such as a tablet or liquid
· Who can use the medicine – for example, only people above a certain age
· How long treatment with that medicine should last
· Warnings about known safety issues – such as side effects and interactions with other medicines
· How the medicine should be stored
When the medicine expires
Explain why the binding of a competitive antagonist to a receptor is a reversible process?
2 marks
A competitive antagonist binds to the same binding site as an agonist. (1/2 mark)
If the concentration of agonist is increased it will replace the binding of the antagonist (1/2 mark) and this will lead to a full tissue response (1/2 mark).
Hence, the antagonism is said to be reversible (1/2 mark).
What is the main route for oral drug absorption?
Passive diffusion via the transcellular pathway
This occurs through enterocytes (simple columnar epithelial cells)
Define the term ‘therapeutic window’.
1 mark
The therapeutic window is the range of drug doses (or drug concentration in the plasma) that produces a therapeutic response without causing significant adverse response (side effects) in the patient.
What is the journey of a drug through the body?
Drug at site of administration
- ABSORPTION -
Drug in plasma
- DISTRIBUTION -
Drug at target organs/tissues
- METABOLISM -
Metabolites in tissues
- ELIMINATION -
Drug or metabolites in urine/faeces
Name the cell type involved in the transcellular pathway which allows oral drugs to be absorbed across the intestine (1/2 mark) AND name one type of membrane transport system in this pathway. [1/2mark]
1 mark
Enterocytes or absorptive cells (1/2 mark)
Any one of the following:
Simple (passive) diffusion
OR carrier-mediated transport
OR active transport (1/2 mark).
What proteins can a drug interact with?
Receptor
Ion channel
Enzyme
Carrier molecule
What are the different types of receptors?
Ligand-gated channels
GPCRs
Enzyme-linked receptors
Intracellular receptors
What is the definition of distribution under ADME?
The reversible transfer of a drug to and from the systemic circulation
The drug has to be unbound (not bound to plasma proteins)
What do drugs bind to?
Proteins in the blood plasma like human serum albumin, lipoproteins, glycoproteins, alpha, beta and gamma globulins
Only unbound drugs can be distributed, metabolised or excreted
What percentage of a drug is usually unbound to plasma proteins?
10%
What is the definition of metabolism in ADME?
Any chemical alteration of a drug by the living system to enhance water solubility and hence excretion
What is the definition of excretion of metabolism in ADME?
The irreversible transfer of a drug from the systemic circulation
Besides binding to its target, what other properties must an oral drug have in order to exert its maximum effect in the body?
Dissolve
Survive a range of pHs (1.5 - 8.0)
Survive intestinal bacteria
Survive liver metabolism
Partition into target organ (get to the receptors where it is needed)
Cross membranes
Avoid excretion by kidneys
Avoid active transport to bile
Avoid partition to non-target organ (in undesired places e.g. brain or foetus)
What happens in the Pre-Clinical Testing of a drug?
How long does this usually last?
Use cells and tissues in culture to test the general effects of the drug (in at least 2 species)
Tests for any potentially life-threatening, deleterious effects
Lasts on average 18 months
What happens Phase 0 of clinical trials?
First time the drug is given to humans (a small group of 10 healthy individuals)
First time pharmacodynamics and pharmacokinetics can be observed in vivo
Checks for any harmful, unforeseeable side effects of the trialed drug
What happens in Phase I of the Clinical Trial?
Still healthy volunteers
Higher cohort
Dose escalation study is implemented to determine the appropriate dosage required to produce the desired effect
What happens in Phase II of a Clinical Trial?
First time actual patients with the condition the drug is supposed to be for are involved
Few hundred participants are given placebo or actual drug
Assess the effectiveness of the new drug by subtracting the placebo’s efficacy from trialled drug
What happens in Phase III of a clinical trail?
Similar to phase II
Several thousands of patients
Increases the reliability of the data
Benefits of the new drug are weighed against side effects
What occurs in Phase 4 of the drug trailing process?
Continous testing and review of the effects of the drug as it is being marketed and sold to the public
Patients can feedback about the effects of the drug to appropriate bodies through the yellow card scheme put in place by the MHRA
What is the MHRA?
Medicines and Healthcare Products Regulatory Agency (MHRA)
The government body that approves and regulates drugs used in healthcare in the UK
Yellow card scheme allows patients to report problems with a drug after it is on the market